Chrysos beats targets

ASSAY technology maker Chrysos Corporation has outperformed the forecast in its prospectus by 3.8%. to post revenue for the 2021-22 financial year of $14.3 million It had forecast $13.7 million.

Chrysos beats targets Chrysos beats targets Chrysos beats targets Chrysos beats targets Chrysos beats targets

One of Chrysos' Photon Assay units in use at Intertek's Perth facility.

That revenue figure was also up 215% on FY21.

It came on the back of 38 lease agreements for Chrysos' PhotonAssay x-ray assay device and 10 deployed units for FY22.